Search

everythinglearnresearchcommunity

for

Search:↓

Iron deficiency worsens inflammatory skin diseases by disrupting iron balance and increasing inflammation.

Upadacitinib improved multiple immune-related conditions in one patient.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Special cells can help regrow hair in alopecia areata.

Restoring nerve-macrophage communication may help treat autoimmune diseases.

Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

The treatment using a special hydrogel shows promise for promoting hair growth.

Urban air pollution worsens hair loss in alopecia areata by increasing immune response.

Arctium lappa L. might help treat immune-related skin diseases, but more research is needed.

Squaric acid dibutylester promotes hair growth by activating immune cells, especially macrophages.

Skin stretching can improve vaccine delivery through hair follicles and boost immune response.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Immune system changes may contribute to female pattern hair loss.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Immune cells and cytokines significantly affect pathological scar development.

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Nanoparticles with specific drugs can help regrow hair in alopecia areata.

Vitiligo treatments include JAK inhibitors, UVB phototherapy, and dietary changes, with emotional support being important.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.